The molecular neurobiology of depression begins with the concept that depressive disorders represent a family of related but distinct conditions. Different points of vulnerability in the brain may predispose a person to depressive disorders. Unraveling these complex causes may lead to novel treatments that can be used in a targeted fashion.
aDepartment of Psychiatry, Vanderbilt University Medical Center, 1500 21st Avenue, South, Suite 2200, Nashville, TN 37212, USA
bDepartment of Pharmacology, Vanderbilt University Medical Center, 1500 21st Avenue, South, Suite 2200, Nashville, TN 37212, USA
Department of Pharmacology, Vanderbilt University Medical Center, 1500 21st Avenue, South, Suite 2200, Nashville, TN 37212.
Supported in part by NIMH grants MH073630, MH01741, and MH52339.
ABSTRACT